M. Craig Hall

4.7k total citations · 2 hit papers
57 papers, 3.4k citations indexed

About

M. Craig Hall is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, M. Craig Hall has authored 57 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 22 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in M. Craig Hall's work include Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (12 papers). M. Craig Hall is often cited by papers focused on Bladder and Urothelial Cancer Treatments (15 papers), Prostate Cancer Treatment and Research (14 papers) and Renal cell carcinoma treatment (12 papers). M. Craig Hall collaborates with scholars based in United States, United Kingdom and Australia. M. Craig Hall's co-authors include Arthur I. Sagalowsky, Peter E. Clark, Claus G. Roehrborn, Thomas Carmody, Brian R. Matlaga, Ronald J. Zagoria, Guido Dalbagni, Sam S. Chang, John D. Seigne and Raj S. Pruthi and has published in prestigious journals such as Cancer, Cancer Research and Clinical Cancer Research.

In The Last Decade

M. Craig Hall

56 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

2007 646 citations M. Craig Hall et al. profile →
Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients

1998 507 citations M. Craig Hall, Arthur I. Sagalowsky et al. Urology profile →

Peers

Countries citing papers authored by M. Craig Hall

Since Specialization

Citations

This map shows the geographic impact of M. Craig Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Craig Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Craig Hall more than expected).

Fields of papers citing papers by M. Craig Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Craig Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Craig Hall. The network helps show where M. Craig Hall may publish in the future.

Co-authorship network of co-authors of M. Craig Hall

This figure shows the co-authorship network connecting the top 25 collaborators of M. Craig Hall. A scholar is included among the top collaborators of M. Craig Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Craig Hall. M. Craig Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Cytokine genetic polymorphisms and prostate cancer aggressiveness	Carcinogenesis	Jovanny Zabaleta, Hui‐Yi Lin et al.	50
2	Complementary and Alternative Medicine for Advanced Prostate Cancer	Urologic Clinics of North America	Peter E. Clark, M. Craig Hall et al.	28
3	Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy	Urology	Peter E. Clark, M. Craig Hall et al.	66
4	DNA damage levels in prostate cancer cases and controls	Carcinogenesis	M. Craig Hall, Peter E. Clark et al.	40
5	Recent advances in the treatment of bladder cancer	Expert Review of Anticancer Therapy	Peter E. Clark, M. Craig Hall et al.	2
6	Contemporary Management of the Urethra in Patients After Radical Cystectomy for Bladder Cancer	Urologic Clinics of North America	Peter E. Clark, M. Craig Hall	10
7	Bladder cancer	Current Opinion in Oncology	Lester S. Borden, Peter E. Clark et al.	13
8	Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma	Urology	Peter E. Clark, M. Craig Hall et al.	15
9	Society of Urologic Oncology position statement: Redefining the management of hormone‐refractory prostate carcinoma	Cancer	Sam S. Chang, Mitchell C. Benson et al.	24
10	Randomized prospective trial of a novel local anesthetic technique for extensive prostate biopsy	Urology	Brian R. Matlaga, James Lovato et al.	36
11	Bladder cancer	Current Opinion in Oncology	Lester S. Borden, Peter E. Clark et al.	40
12	Bladder cancer	Current Opinion in Oncology	Suzanne E. Patton, M. Craig Hall et al.	27
13	A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy	International Journal of Radiation OncologyBiologyPhysics	W. Robert Lee, M. Craig Hall et al.	103
14	URETEROSCOPIC MANAGEMENT OF PATIENTS WITH UPPER TRACT TRANSITIONAL CELL CARCINOMA	Urologic Clinics of North America	Dean G. Assimos, M. Craig Hall et al.	21
15	Are differences in interleukin 10 production associated with joint damage?	Lara D. Veeken	T. Huizinga, V. Keijsers et al.	79
16	Recent advances in the treatment of prostate cancer	Annals of Oncology	W. Robert Lee, Ricky L. Bare et al.	24
17	Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer	Urology	M. Craig Hall, Arthur I. Sagalowsky et al.	67
18	Frequency and characterization of p53 mutations in clinically localized prostate cancer	Urology	M. Craig Hall, Nora M. Navone et al.	53
19	Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations	Urologic Oncology Seminars and Original Investigations	Haiyen E. Zhau, Leland W.K. Chung et al.	17
20	Significance of tumor angiogenesis inclinically localized prostate carcinoma treated with external beam radiotherapy	Urology	M. Craig Hall, Patricia Troncoso et al.	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact